Brigham Inc

Brigham Inc is a research organisation in Boston, United States that has taken part in 25 EU-funded projects since 2010, receiving €3.7M in EU funding.

EU funding received€3.7M
EU projects25
As coordinator0
Running now10
First EU project2010
Latest project2026
CountryUnited States
EU registration (PIC)995688026
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Brigham Inc's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.9M · 4 projects
  • Horizon Europe€1.7M · 12 projects
  • Horizon 2020€51k · 9 projects

Projects

25 EU-funded projects, newest first. Each links to the official record.

  • Electro-NervogelAssociated partner

    Multifunctional Electromagnetic Injectable Hydrogel for Treating Osteochondral Defect Via Neurostimulated Bone Regeneration

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • GlioZEROAssociated partner

    Advanced technologies for zeroing in on high-grade gliomas

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • NEURO-SEEDAssociated partner

    Neuroendocrine Seeds of Obesity

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

  • Micro-InsulinAssociated partner

    Prototype Spiked Microcapsule based Oral Insulin Pill For Diabetes.

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • PlateCAV-3DAssociated partner

    Delineating PLATElet-induced sex-specific responses in Calcific Aortic Valve disease using 3D-bioprinting and proteomics.

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • ReModel-OPAssociated partner

    Identifying strategies to reduce osteoporosis-driven bone loss through the development of microphysiological bone remodeling-on-chip tools

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • dAIbetesPartner

    Federated virtual twins for privacy-preserving personalised outcome prediction of type 2 diabetes treatment

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €476ktheir share
  • VoluFaTEAssociated partner

    VoluFaTE: Volumetric programming of cells to control the fate and function of engineered tissues

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • CLOCKriskPartner

    Targeting the circadian clock in personalized disease prevention

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €456ktheir share
  • MACROVALVEPartner

    Understanding the role of macrophages in the structural degeneration of bioprosthetic heart valve leaflets

    Horizon 2020 · 2022–2025 · Project on CORDIS ↗

  • REPO4EUPartner

    Precision drug REPurpOsing For EUrope and the world

    Horizon Europe · 2022–2029 · Project on CORDIS ↗

    €767ktheir share
  • Th17 tissue metabAssociated partner

    Metabolic imprinting of Th17 cells in disease pathogenesis

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

  • GLIORESOLVEAssociated partner

    Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

  • BrainChip4MEDPartner

    Brain-on-a-chip as a preclinical model tool for the screening of theranostic nanoformulations for neurodegenerative diseases

    Horizon 2020 · 2022–2024 · Project on CORDIS ↗

  • neuronsXnetsPartner

    Network Analysis in Neocortex during Passive and Active Learning

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  • DynChanPartner

    Dynamic regulation of paracellular channel gating

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

  • PRINT-CHEMOPartner

    To develop 3D bioPRINTed osteoinductive constructs that deliver CHEMOtherapeutics within large bone defects that are surgically created when removing bone tumours.

    Horizon 2020 · 2019–2022 · Project on CORDIS ↗

  • STOPFOPPartner

    Saracatinib Trial tO Prevent FOP

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €2ktheir share
  • HOXA9 degradomePartner

    Deciphering the machinery involved in stability of the transcription factor HOXA9.

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

  • DANTEPartner

    Use of novel techniques to identify pathogenic versus non-pathogenic TH17 cells in experimental autoimmune encephalomyelitis, a murine model of multiple sclerosis.

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

  • FORCEPartner

    Imaging the Force of Cancer

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €49ktheir share
  • EPISTOPPartner

    Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – tuberous sclerosis complex

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €653ktheir share
  • IMMODGELPartner

    Local Immunomodulation around implants by innovative auxiliary hydrogel-based systems encapsulating autologous and phenotype controlled macrophages

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €581ktheir share
  • SAFEGUARDPartner

    Safety Evaluation of Adverse Reactions in Diabetes

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €223ktheir share
  • CHANCESPartner

    Consortium on Health and Ageing: Network of Cohorts in Europe and the United States

    FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

    €443ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • additive manufacturing
  • alzheimer
  • big data
  • biochemistry
  • biomaterials
  • biomolecules
  • biosensors
  • cardiology
  • cardiovascular diseases
  • cell biology
  • computational science
  • data protection
  • data science
  • databases

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime